Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USA.

Lancet Infect DisJun 9, 2026 (epub)

Erlinda R Ulloa, Daniel Jaffurs, M Tuan Tran et al.

✦ AI-curated · Sources linked

Case in brief

A young woman with acute myeloid leukaemia presented with calciphylaxis, characterized by arteriolar calcification and ischemic skin necrosis. Her condition was complicated by superinfection with a pan-resistant New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa. Management included the novel use of cefepime-zidebactam and bacteriophage therapy, leading to a favorable outcome despite the complexity of her diagnosis.

What made this case unusual

The case involved one of the earliest domestically acquired isolates of a pan-resistant Pseudomonas aeruginosa, which is typically associated with international travel.

Diagnostic / clinical pearl

Clinicians should consider calciphylaxis in patients with acute myeloid leukaemia presenting with ischemic skin lesions, especially when complicated by unusual infections.

Why it matters

This case underscores the importance of innovative therapeutic strategies in managing complex infections associated with rare conditions like calciphylaxis.

Source

Published in Lancet Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Hematology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.